Skip to content
Nanomed logo — Empowering healthcare with advanced graphene biosensors for...

Nanomed

Empowering healthcare with advanced graphene biosensors for accelerated life science and drug discovery research.

Founded 2013 Series A Total: $2.40M Biotechnology, Health Care +2

General Information

Company Name Nanomed
Founded Year 2013
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Nanomed. To contact Nanomed, visit nanomedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nanomed compare?

A PDF of Nanomed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nanomed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nanomed

Nanomed is a biotechnology company founded in 2013 and based in San Diego, California. Specializing in advanced graphene biosensor products, Nanomed is committed to empowering healthcare through accelerated life science and drug discovery research. Their innovative electrical assay, based on proprietary Field Effect Biosensing (FEB) technology, enables label-free, highly sensitive binding studies of small molecules to proteins, offering advantages such as a wide dynamic range and minimal signal interference. Recently, the company secured Series A investment from SandHill Angels on October 23, 2020. As the foremost mass-manufacturer of advanced graphene biosensors, Nanomed aims to revolutionize the healthcare industry by introducing new products supporting life science and drug discovery research.

Business keywords: Graphene Biosensors, Drug Discovery, Life Science Research, Healthcare Innovation, Diagnostic Tools, Field Effect Biosensing, Small Molecule Detection, Electrical Assay, Health Monitoring, San Diego, Nanotechnology, Innovative Technology, Health-Tech, Mass-Manufacturing

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
SandHill Angels
23 Oct 2020
Series A Undisclosed 1
SandHill Angels
01 Jan 2019
Venture Round Undisclosed 1
Serra Ventures
21 Jul 2017
Venture Round Undisclosed 1
Serra Ventures
17 Apr 2017
Venture Round Undisclosed 1
Serra Ventures
14 Dec 2016
Venture Round Undisclosed 1
Serra Ventures
30 Jun 2016
Convertible Note $600.00K 1
Serra Ventures
15 Jan 2016
Series A $1.60M 2
Serra Ventures, SandHill Angels
13 Oct 2015
Venture Round Undisclosed 3
Serra Ventures, SandHill Angels +1
22 Apr 2015
Debt Financing $200.00K -
13 Oct 2014

View All 11 Funding Rounds

Nanomed Alternatives & Competitors

View All Alternatives
Nanomed vs

Empowering genomic research and drug discovery with micro and nano-scale technology platforms for im...

Series C
Biotechnology, Health Care
Nanomed vs

Addressing urgent unmet medical needs through deeper science, true originality, and rich experience....

Series B
69 employees
Biopharma, Biotechnology
Nanomed vs
858 Therapeutics
858 Therapeutics United States

Discovering innovative small molecule therapeutics for the treatment of cancer

Venture round
30 employees
Biotechnology, Health Care

FAQ About Nanomed

Empowering healthcare with advanced graphene biosensors for accelerated life science and drug discovery research.
Nanomed was founded in 2013.
Nanomed operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical. Its work centres on Graphene Biosensors, Drug Discovery, Life Science Research and Healthcare Innovation.
Nanomed has completed 11 funding rounds, raising a total of $2.40M. The latest funding stage is Series A.
Top alternatives and competitors to Nanomed include BioTrove, BlossomHill Therapeutics, Inc., 858 Therapeutics, Panacos Pharmaceuticals, ALSP, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanomed and BioTrove are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nanomed, https://bouncewatch.com/company/nanomed-1, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout